Optimizing The Quantity and Quality of GLP-1 Weight Loss: Evidence from a 12-Week Comparative Study GLP1 medications have changed whats possible for weight loss, but they also raise a critical question: what are people losingfat, lean mass, or both
Khng khuyn dng thuc Glutaone 600 cho ph n ang mang thai v cho con b (d cc nghin cu th nghim cho thy khng c bng chng v c tnh ca thuc ln phi bo)
10.1007/s00203-017-1459-x Summary Keywords gut microbiota, gastrointestinal diseases, cancer, therapy, dysbiosis Citation Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman SU, Suleman, Ullah I, Hassan IU, Tian Y and Li K (2025) Gut microbiota therapy in gastrointestinal diseases
As a result, patients may benefit from more accurate and personalised management strategies
*Correspondence: Jie Sun, [email protected]